Literature DB >> 19859746

Natural course of HCV infection in childhood cancer survivors.

Francesca Fioredda1, Andrea Moser, Luisella Bertoluzzo, Herwig Lackner, Raffaella Giacchino, Milena La Spina, Luisella Lazier, Caterina Riva, Mareva Giacchino, Donatella Fraschini, Eva Frey, Angela Sementa, Angela Pistorio, Riccardo Haupt.   

Abstract

GOALS OF WORK: To describe the course of hepatitis C in a cohort of 105 survivors after childhood cancer. PATIENTS AND METHODS: Data on chemo/radiotherapy, clinical status, serial alanine aminotransferase (ALT) evaluation, and virological parameters after the end of treatment were collected for each patient. Liver biopsies, when performed, were centrally evaluated by a pathologist. MAIN
RESULTS: All patients were alive at the end of follow-up and did not show hepatic insufficiency. ALT evaluation along the entire follow-up showed a moderate (87%) or a remarkable (13%) cytolytic pattern. Young age at diagnosis, hematopoietic stem cell transplantation, and duration of infection significantly correlate with a worse hepatic activity. Type of tumor and chemo and/or radiotherapy regimens did not influence the pattern of hepatic cytolysis. Liver biopsy, centrally reviewed in 30% of the cohort, showed one case of cirrhosis and mild fibrosis in 71% of the group. Higher degrees of fibrosis did not seem to be related to any exposition to chemo/radiotherapy but correlated significantly with the more remarkable cytolytic course.
CONCLUSIONS: The outcome of hepatitis C in our patients is comparable to the one described in European cohorts of adult cancer survivors and perinatally infected subjects. Nevertheless, progression to high degrees of hepatic damage has to be monitored by a careful follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19859746     DOI: 10.1007/s00520-009-0763-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  35 in total

Review 1.  Scoring of chronic hepatitis.

Authors:  Peter J Scheuer; Richard A Standish; Amar P Dhillon
Journal:  Clin Liver Dis       Date:  2002-05       Impact factor: 6.126

2.  Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.

Authors:  M Vogt; T Lang; G Frösner; C Klingler; A F Sendl; A Zeller; B Wiebecke; B Langer; H Meisner; J Hess
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

3.  The long-term pathological evolution of chronic hepatitis C.

Authors:  M Yano; H Kumada; M Kage; K Ikeda; K Shimamatsu; O Inoue; E Hashimoto; J H Lefkowitch; J Ludwig; K Okuda
Journal:  Hepatology       Date:  1996-06       Impact factor: 17.425

4.  The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort.

Authors:  Sharon Castellino; Shelly Lensing; Caroline Riely; Shesh N Rai; Rene Davila; Randall T Hayden; Jackie Fleckenstein; Mark Levstik; Shari Taylor; Patrick J Dean; Sarah Kippenbrock; Jennifer Pope; Jeanne Carr; Donald K Strickland; Melissa M Hudson
Journal:  Blood       Date:  2003-12-18       Impact factor: 22.113

5.  Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

Authors:  C Niederau; S Lange; T Heintges; A Erhardt; M Buschkamp; D Hürter; M Nawrocki; L Kruska; F Hensel; W Petry; D Häussinger
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

6.  Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

Authors:  Zachary D Goodman; Hala R Makhlouf; Lea Liu; William Balistreri; Regino P Gonzalez-Peralta; Barbara Haber; Maureen M Jonas; Parvathi Mohan; Jean P Molleston; Karen F Murray; Michael R Narkewicz; Philip Rosenthal; Lesley J Smith; Patricia R Robuck; Kathleen B Schwarz
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

7.  Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Authors:  Pierluigi Toniutto; Carlo Fabris; Davide Bitetto; Edmondo Falleti; Claudio Avellini; Elisabetta Rossi; Carlo Smirne; Rosalba Minisini; Mario Pirisi
Journal:  J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 4.029

Review 8.  Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

Authors:  Leonard B Seeff; Jay H Hoofnagle
Journal:  Clin Liver Dis       Date:  2003-02       Impact factor: 6.126

9.  Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth.

Authors:  Maria Antonietta Casiraghi; Massimo De Paschale; Luisa Romanò; Renato Biffi; Agnese Assi; Giorgio Binelli; Alessandro Remo Zanetti
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

10.  The natural history of hepatitis C virus (HCV) infection.

Authors:  Stephen L Chen; Timothy R Morgan
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

View more
  2 in total

1.  Long-term follow-up for incident cirrhosis among pediatric cancer survivors with hepatitis C virus infection.

Authors:  Sericea Stallings-Smith; Kevin R Krull; Tara M Brinkman; Melissa M Hudson; Rohit P Ojha
Journal:  J Clin Virol       Date:  2015-07-29       Impact factor: 3.168

2.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.